Company Filing History:
Years Active: 2010-2011
Title: Malcolm L Kennard: Innovator in Blood-Brain Barrier Transport
Introduction
Malcolm L Kennard is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of medical science, particularly in the area of blood-brain barrier transport. With a total of 2 patents, his work focuses on enhancing the delivery of therapeutic agents to the central nervous system.
Latest Patents
Kennard's latest patents include innovative compositions and methods for modulating blood-brain barrier transport. One of his inventions provides conjugates of therapeutic or active agents with melanotransferrin or other ligands of a melanotransferrin receptor. This invention outlines methods for screening and selecting such conjugates, ligands, and modulators both in vitro and in vivo. It also details the use of these conjugates, modulators, and ligands in diagnosing and treating diseases, particularly those affecting the central nervous system or lysosomal storage diseases. Another patent similarly focuses on compositions for modulating blood-brain barrier transport, emphasizing the importance of these conjugates and their potential applications in medical treatments.
Career Highlights
Throughout his career, Kennard has worked with prominent companies in the pharmaceutical industry, including Raptor Pharmaceuticals Inc. and Raptor Pharmaceutical Corp. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical therapies.
Collaborations
Kennard has collaborated with esteemed colleagues such as Richard Beliveau and Michel Demeule. These partnerships have further enriched his research and development efforts in the field of blood-brain barrier transport.
Conclusion
Malcolm L Kennard's contributions to the field of medical science, particularly through his patents on blood-brain barrier transport, highlight his innovative spirit and dedication to improving therapeutic delivery systems. His work continues to pave the way for advancements in the treatment of central nervous system diseases.